Your browser doesn't support javascript.
loading
Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo-controlled CARMELINA® trial.
Cooper, Mark E; Rosenstock, Julio; Kadowaki, Takashi; Seino, Yutaka; Wanner, Christoph; Schnaidt, Sven; Clark, Douglas; Johansen, Odd Erik.
Afiliación
  • Cooper ME; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, Texas.
  • Kadowaki T; University of Texas, Southwestern Medical Center, Dallas, Texas.
  • Seino Y; Department of Prevention of Diabetes and Lifestyle-related Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
  • Wanner C; Department of Metabolism and Nutrition, Mizonokuchi Hospital, Faculty of Medicine, Teikyo University, Kanagawa, Japan.
  • Schnaidt S; Kansai Electric Power Medical Research Institute, Osaka, Japan.
  • Clark D; Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan.
  • Johansen OE; Division of Nephrology, Department of Medicine, Würzburg University Clinic, Würzburg, Germany.
Diabetes Obes Metab ; 22(7): 1062-1073, 2020 07.
Article en En | MEDLINE | ID: mdl-32037653
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Enfermedades Renales Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Enfermedades Renales Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article País de afiliación: Australia